Treatment for Urinary Frequency

Initial Assessment

The American College of Physicians recommends determining the type of urinary symptoms through focused questioning about timing, triggers, and associated symptoms, and obtaining urinalysis to rule out urinary tract infection or other pathology, with moderate-quality evidence 3
Assessing post-void residual volume is recommended to identify potential urinary retention, with moderate-quality evidence 3
Validated questionnaires can be used for more accurate diagnosis, with moderate-quality evidence 3

The American College of Physicians recommends bladder training as the first-line treatment, with strong evidence for effectiveness and minimal side effects, particularly in elderly women who have a 75% prevalence of urinary incontinence 1, 2, 4
Bladder training involves implementing scheduled voiding intervals that gradually increase over time, with strong recommendation and moderate-quality evidence 1, 2, 4
Pelvic Floor Muscle Training (PFMT) can be combined with bladder training for mixed urinary incontinence, with strong recommendation and moderate-quality evidence 1, 2, 4, 5

The American College of Physicians recommends antimuscarinic medications, such as solifenacin, tolterodine, and oxybutynin, as second-line treatment for urgency urinary incontinence, with strong recommendation and high-quality evidence 1, 4, 6
Antimuscarinic medications have significant side effects, including dry mouth, constipation, and blurred vision, and should be used with caution in elderly patients due to increased risk of cognitive side effects 6, 7

The American Geriatrics Society recommends using antimuscarinic medications with caution in elderly patients, considering lower starting doses and monitoring for drug interactions, with moderate-quality evidence 7
Antimuscarinic medications should be avoided in patients with narrow-angle glaucoma, impaired gastric emptying, or history of urinary retention, with moderate-quality evidence 7

The American Urological Association recommends assessing treatment response using voiding diaries to document frequency and volume, and evaluating for medication side effects, particularly with antimuscarinic agents, with moderate-quality evidence 6, 7
Clinically successful treatment is defined as reducing the frequency of urinary incontinence episodes by at least 50%, with moderate-quality evidence 1